Abstract:Parathyroid hyperplasia of all four glands was found to be the cause of primary hyperparathyroidism in 85 of 557 cases seen at the Massachusetts General Hospital between 1930 and 1973. There were 66 cases of chief cell hyperplasia and 19 cases of clear cell hyperplasia that were grossly, microscopically, and ultrastructurally distinct. Although the clinical findings overlap, there are several differences in the signs and symptoms between these two forms of hyperplasia. Both types are treated by subtotal remova… Show more
“…approach (11 -13), or even minimally invasive (14), video-assisted parathyroid surgery (10,15), the potential benefits of these procedures being the decreased risk of postoperative hypocalcemia, nerve injury and shorter operating time (16 -18). The main limitation of these latter procedures is the possibility of a multiglandular disease in up to 15 -20% of cases of sporadic PHPT, a condition that cannot often be identified preoperatively (5,6).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover in some circumstances it is difficult to distinguish normal from abnormal glands either at the operating table or by frozen section. Indeed in most cases the pathologist can only indicate if the biopsied lump is a parathyroid, but not whether it is normal or abnormal (5,6).…”
Objective: The traditional surgical approach for patients with primary hyperparathyroidism (PHPT) consists of the identification of at least four glands and in the removal of all hyperfunctioning parathyroid tissue. Design: To evaluate whether intraoperative parathyroid hormone (PTH) monitoring will allow a more limited surgical procedure by confirming complete removal of all hyperfunctioning tissue. Methods: Plasma samples were obtained from 206 consecutive patients with sporadic PHPT before skin incision, during manipulation of a suspected adenoma, and 5 min (T-5) and 10 min after removal of abnormal parathyroid tissue. PTH was measured by a quick immunochemiluminescent assay (QPTH). The operative success was defined by a decrease of PTH greater than 50% of the highest pre-excision value. Results: A .50% decrease of PTH occurred in 203 patients and was evident at T-5 in the majority of cases. All but three had normal serum calcium the day after surgery and afterwards. PTH concentration did not show a . 50% decrease in the remaining three cases after completion of surgery. One patients had negative neck exploration and remained hypercalcemic; the other two had normal serum calcium at follow-up. Thus, the intraoperative QPTH correctly predicted the outcome of surgery in 201 patients (97.5%) (200 true positive and 1 true negative), and provided three false positive and two false negative results. Conclusions: The intraoperative QPTH measurement represents a useful tool to assist the surgeon during parathyroidectomy. It indicates whether all hyperfunctioning parathyroid tissue has been removed, limiting the procedure to a unilateral neck exploration in most cases.
“…approach (11 -13), or even minimally invasive (14), video-assisted parathyroid surgery (10,15), the potential benefits of these procedures being the decreased risk of postoperative hypocalcemia, nerve injury and shorter operating time (16 -18). The main limitation of these latter procedures is the possibility of a multiglandular disease in up to 15 -20% of cases of sporadic PHPT, a condition that cannot often be identified preoperatively (5,6).…”
Section: Discussionmentioning
confidence: 99%
“…Moreover in some circumstances it is difficult to distinguish normal from abnormal glands either at the operating table or by frozen section. Indeed in most cases the pathologist can only indicate if the biopsied lump is a parathyroid, but not whether it is normal or abnormal (5,6).…”
Objective: The traditional surgical approach for patients with primary hyperparathyroidism (PHPT) consists of the identification of at least four glands and in the removal of all hyperfunctioning parathyroid tissue. Design: To evaluate whether intraoperative parathyroid hormone (PTH) monitoring will allow a more limited surgical procedure by confirming complete removal of all hyperfunctioning tissue. Methods: Plasma samples were obtained from 206 consecutive patients with sporadic PHPT before skin incision, during manipulation of a suspected adenoma, and 5 min (T-5) and 10 min after removal of abnormal parathyroid tissue. PTH was measured by a quick immunochemiluminescent assay (QPTH). The operative success was defined by a decrease of PTH greater than 50% of the highest pre-excision value. Results: A .50% decrease of PTH occurred in 203 patients and was evident at T-5 in the majority of cases. All but three had normal serum calcium the day after surgery and afterwards. PTH concentration did not show a . 50% decrease in the remaining three cases after completion of surgery. One patients had negative neck exploration and remained hypercalcemic; the other two had normal serum calcium at follow-up. Thus, the intraoperative QPTH correctly predicted the outcome of surgery in 201 patients (97.5%) (200 true positive and 1 true negative), and provided three false positive and two false negative results. Conclusions: The intraoperative QPTH measurement represents a useful tool to assist the surgeon during parathyroidectomy. It indicates whether all hyperfunctioning parathyroid tissue has been removed, limiting the procedure to a unilateral neck exploration in most cases.
“…Most patients with pHPT (80%-85%) have a single adenoma, whereas only 15% to 20% have multigland involvement. [2][3][4][5][6][7][8] Our appreciation of clinical manifestationsCorrespondence to: B. Larian
…”
“…There are some histopathologic features which are associated with malignancy, though they are certainly not pathognomonic for carcinoma. Worrisome features include the presence of increased or atypical mitoses, broad bands of fibrosis, trabecular growth pattern, invasion of adjacent tissue, and perineural or angiolymphatic invasion [29]. These features usually correlate with malignancy, though these histologic features are not always present in every case of parathyroid carcinoma [25,30,31].…”
Section: Parathyroid Carcinoma: Illustration Of a Tumor Suppressor Genementioning
Molecular alterations in tumors have become interesting targets both for diagnostic and for therapeutic and prognostic applications in tumor pathology. In the head and neck, there are a variety of different alterations, encompassing all the different types of genetic events associated with carcinogenesis. This paper reviews three different types of tumors that display a spectrum of genetic alterations: the translocation in Mucoepidermoid carcinoma, Epstein Barr virus association in nasopharyngeal carcinoma, and the HRPT2 tumor suppressor gene in parathyroid carcinoma. Basic histology is reviewed and the genetic alterations are discussed, along with a brief discussion of potential diagnostic implications.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.